Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in DFTX — Definium Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA
Back to DFTX Full portfolio

Position in DFTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,926,476
+$386,958 QoQ
Shares Held
40,954
-49.7% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DFTX Over Time

Shares Held

Position Value (USD)

Derivatives in DFTX

reported options exposure · as of Jun 30, 2026
CallValue
$65,216,256
CallShares
1,386,400
PutValue
$22,155,840
PutShares
471,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,280,390 across 349 Biotechnology names. DFTX ranks #87 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in DFTX

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,926,476 40,954
2026-06-30 $22,155,840 471,000
2026-06-30 $65,216,256 1,386,400
2026-03-31 $4,086,180 216,200
2026-03-31 $15,876,000 840,000
2026-03-31 $1,539,518 81,456